Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

Por Eto, K, Kawakami, H, Kuwatani, M, Kudo, T, Abe, Y, Kawahata, S, Takasawa, A, Fukuoka, M, Matsuno, Y, Asaka, M, Sakamoto, N
Publicado em 2013